These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. Brener SJ, Maehara A, Dizon JM, Fahy M, Witzenbichler B, Parise H, El-Omar M, Dambrink JH, Mehran R, Oldroyd K, Gibson CM, Stone GW. JACC Cardiovasc Interv; 2013 Jul; 6(7):718-24. PubMed ID: 23866184 [Abstract] [Full Text] [Related]
3. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. Stone GW, Maehara A, Witzenbichler B, Godlewski J, Parise H, Dambrink JH, Ochala A, Carlton TW, Cristea E, Wolff SD, Brener SJ, Chowdhary S, El-Omar M, Neunteufl T, Metzger DC, Karwoski T, Dizon JM, Mehran R, Gibson CM, INFUSE-AMI Investigators. JAMA; 2012 May 02; 307(17):1817-26. PubMed ID: 22447888 [Abstract] [Full Text] [Related]
4. Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial. Brener SJ, Witzenbichler B, Maehara A, Dizon J, Fahy M, El-Omar M, Dambrink JH, Genereux P, Mehran R, Oldroyd K, Parise H, Gibson CM, Stone GW. Am Heart J; 2013 Jul 02; 166(1):64-70. PubMed ID: 23816023 [Abstract] [Full Text] [Related]
5. Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. Gibson CM, Maehara A, Lansky AJ, Wohrle J, Stuckey T, Dave R, Cox D, Grines C, Dudek D, Steg G, Parise H, Wolff SD, Cristea E, Stone GW. Am Heart J; 2011 Mar 02; 161(3):478-486.e7. PubMed ID: 21392601 [Abstract] [Full Text] [Related]
9. Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration. Gu YL, Fokkema ML, Kampinga MA, de Smet BJ, Tan ES, van den Heuvel AF, Zijlstra F. Trials; 2009 Sep 28; 10():90. PubMed ID: 19785725 [Abstract] [Full Text] [Related]
15. Optimization in stent implantation by manual thrombus aspiration in ST-segment-elevation myocardial infarction: findings from the EXAMINATION trial. Fernández-Rodríguez D, Regueiro A, Brugaletta S, Martín-Yuste V, Masotti M, Cequier A, Iñíguez A, Serra A, Hernández-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Serruys PW, Sabaté M, EXAMINATION investigators. Circ Cardiovasc Interv; 2014 Jun 01; 7(3):294-300. PubMed ID: 24867891 [Abstract] [Full Text] [Related]
16. Synergistic effect of thrombus aspiration and abciximab in primary percutaneous coronary intervention. Pyxaras SA, Mangiacapra F, Verhamme K, Di Serafino L, De Vroey F, Toth G, Perkan A, Salvi A, Bartunek J, De Bruyne B, Wijns W, Sinagra G, Barbato E. Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):604-11. PubMed ID: 23359568 [Abstract] [Full Text] [Related]
17. Usefulness of the Left Anterior Descending Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (an INFUSE-AMI Substudy). Kobayashi N, Maehara A, Mintz GS, Wolff SD, Généreux P, Xu K, Mehran R, Gibson CM, Brener SJ, Stone GW. Am J Cardiol; 2015 May 15; 115(10):1389-95. PubMed ID: 25770973 [Abstract] [Full Text] [Related]
18. Outcomes in patients with ST-segment elevation acute myocardial infarction treated with clopidogrel versus prasugrel (from the INFUSE-AMI trial). Brener SJ, Oldroyd KG, Maehara A, El-Omar M, Witzenbichler B, Xu K, Mehran R, Gibson CM, Stone GW. Am J Cardiol; 2014 May 01; 113(9):1457-60. PubMed ID: 24630789 [Abstract] [Full Text] [Related]
19. Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention--effects on soluble CD40 ligand concentrations. Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P, Bosa-Ojeda F, Samimi-Fard S, Marrero-Rodriguez F, Kaski JC. Atherosclerosis; 2009 Oct 01; 206(2):523-7. PubMed ID: 19380134 [Abstract] [Full Text] [Related]
20. Randomized trial of standard versus ClearWay-infused abciximab and thrombectomy in myocardial infarction: rationale and design of the COCTAIL II study. Prati F, Di Vito L, Ramazzotti V, Imola F, Pawlowski T, Materia L, Tavazzi L, Biondi-Zoccai G, Albertucci M. J Cardiovasc Med (Hagerstown); 2013 May 01; 14(5):364-71. PubMed ID: 22929568 [Abstract] [Full Text] [Related] Page: [Next] [New Search]